Response of low HER2-expressing ovarian carcinosarcoma to trastuzumab deruxtecan, a case report

被引：1
作者：
Rose, Peter G. [1 ]
机构：
[1] Cleveland Clin, Womens Hlth Inst, Sect Gynecol Oncol, A 81,9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
GYNECOLOGIC ONCOLOGY REPORTS | 2023年 / 50卷
关键词：
UTERINE; HER-2/NEU; ONCOGENE;
D O I：
10.1016/j.gore.2023.101311
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 15 条
  • [1] BERCHUCK A, 1990, CANCER RES, V50, P4087
  • [2] HER2 Testing in Endometrial Serous Carcinoma Time for Standardized Pathology Practice to Meet the Clinical Demand
    Buza, Natalia
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (06) : 687 - 691
  • [3] Molecular variations in uterine carcinosarcomas identify therapeutic opportunities
    Crane, Erin
    Naumann, Wendel
    Tait, David
    Higgins, Robert
    Herzog, Thomas
    Brown, Jubilee
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (04) : 480 - 484
  • [4] Current management of ovarian carcinosarcoma
    Mano, M. S.
    Rosa, D. D.
    Azambuja, E.
    Ismael, G.
    Braga, S.
    D'Hondt, V.
    Piccart, M.
    Awada, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (02) : 316 - 324
  • [5] Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression
    Mauricio, Dennis
    Bellone, Stefania
    Mutlu, Levent
    McNamara, Blair
    Manavella, Diego D.
    Demirkiran, Cem
    Verzosa, Miguel Skyler Z.
    Buza, Natalia
    Hui, Pei
    Hartwich, Tobias Max Philipp
    Harold, Justin
    Yang-Hartwich, Yang
    Zipponi, Margherita
    Altwerger, Gary
    Ratner, Elena
    Huang, Gloria S.
    Clark, Mitchell
    Andikyan, Vaagn
    Azodi, Masoud
    Schwartz, Peter E.
    Santin, Alessandro D.
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 170 : 38 - 45
  • [6] Meric-Bernstam F., 2023, LBA 3000 ASCO 2023
  • [7] Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
    Modi, Shanu
    Jacot, William
    Yamashita, Toshinari
    Sohn, Joohyuk
    Vidal, Maria
    Tokunaga, Eriko
    Tsurutani, Junji
    Ueno, Naoto T.
    Prat, Aleix
    Chae, Yee Soo
    Lee, Keun Seok
    Niikura, Naoki
    Park, Yeon Hee
    Xu, Binghe
    Wang, Xiaojia
    Gil-Gil, Miguel
    Li, Wei
    Pierga, Jean-Yves
    Im, Seock-Ah
    Moore, Halle C. F.
    Rugo, Hope S.
    Yerushalmi, Rinat
    Zagouri, Flora
    Gombos, Andrea
    Kim, Sung-Bae
    Liu, Qiang
    Luo, Ting
    Saura, Cristina
    Schmid, Peter
    Sun, Tao
    Gambhire, Dhiraj
    Yung, Lotus
    Wang, Yibin
    Singh, Jasmeet
    Vitazka, Patrik
    Meinhardt, Gerold
    Harbeck, Nadia
    Cameron, David A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (01) : 9 - 20
  • [8] Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial
    Nishikawa, Tadaaki
    Hasegawa, Kosei
    Matsumoto, Koji
    Mori, Masahiko
    Hirashima, Yasuyuki
    Takehara, Kazuhiro
    Ariyoshi, Kazuya
    Kato, Tomoyasu
    Yagishita, Shigehiro
    Hamada, Akinobu
    Kawasaki, Mamiko
    Kawashima, Satoshi
    Tomatsuri, Sawako
    Nagasaka, Yukari
    Yoshida, Hiroshi
    Machida, Ryunosuke
    Hirakawa, Akihiro
    Nakamura, Kenichi
    Yonemori, Kan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2789 - +
  • [9] Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
    Powell, Matthew A.
    Filiaci, Virginia L.
    Hensley, Martee L.
    Huang, Helen Q.
    Moore, Kathleen N.
    Tewari, Krishnansu S.
    Copeland, Larry J.
    Secord, Angeles A.
    Mutch, David G.
    Santin, Alessandro
    Warshal, David P.
    Spirtos, Nick M.
    DiSilvestro, Paul A.
    Ioffe, Olga B.
    Miller, David S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (09) : 968 - +
  • [10] Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis
    Rauh-Hain, J. Alejandro
    Gonzalez, Rafael
    Bregar, Amy J.
    Clemmer, Joel
    Hernandez-Blanquisett, Abraham
    Clark, Rachel M.
    Schorge, John O.
    del Carmen, Marcela G.
    [J]. GYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 38 - 43
12